Author Archive
Management
Analysis: Could Pressure for COVID-19 Drugs Lead the FDA to Lower Its Standards?
The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?
